Skip to main content

Life Science Startups

Updated November 2026

Companies in the life science sector developing innovative solutions and technologies.

Explore 1,587 recently funded life science companies with verified founder contact information and fundraising data.

Total Companies
1,587
Total Funding
$2.2B
Avg Funding
$89.6M
Global Reach
11
countries

Top Cities for Life Science

Milano
South San Francisco
San Diego
La Jolla
Ghent
Toronto

Recently Funded Companies

Export
Milano, Italy

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

$141.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.

$300K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Alume Biosciences is a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use.

$3.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

La Jolla, United States

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

$825.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Ghent, Belgium

AmphiStar is a biotechnology firm that makes sophorolipid products from biobased waste- and side streams.

$2.9M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products.

$325K raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

$157.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Solna, Sweden

Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications.

$12.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Donostia-san Sebastián, Spain

Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies

$3.5M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cranberry Twp, United States

NÖK Therapeutics is a biotechnology company that offers NK cell therapies to deepen remissions and drive cures in high-relapse cancers.

$1.1M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Oslo, Norway

Kure Cells is a biotechnology company developing rapid-manufacturing platforms for CAR-T and gene-modified cell therapies.

$10.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Oslo, Norway

Aurora Analytica advances global health by optimizing the clinical trial lifecycle with cutting-edge technology and AI.

$50K raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

$250.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Roatán, Honduras

Unlimited Bio leads in gene therapy for rejuvenation.

$40.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Durham, United States

InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.

$1.9M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Mekiri Bio is a biotechnology company.

$1.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Berlin, Germany

AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.

$149.5M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

New York, United States

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

$154.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Weave Bio is an AI-native platform transforming regulatory workflows and accelerating how novel therapies reach patients faster.

$20.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Naples, United States

ImmunoProfile is a biotechnology company that focuses on manufacturing diagnostic kits for multiple therapeutic areas.

$225K raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Tailored Genes develops tailored lentivirus vectors for delivering precise therapeutic genes to target cells.

$1.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Munich, Germany

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

$400.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

$13.3M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Seattle, United States

Monod Bio is a life sciences company developing biosensors for protein and other analyte detection.

$750K raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Tr1x is a biotechnology company developing novel cellular immunotherapies for patients with autoimmune and inflammatory diseases.

$50.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Showing 426 to 450 of 1,587 companies

About the Life Science Startup Ecosystem

The life science sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Life Science

Life Science companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The life science sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Life Science Funding Breakdown

Here is how funding is distributed among the 1,587 life science companies tracked in the VCBacked database.

Average Funding
$89.6M
Total Funding Tracked
$2.2B
Countries Represented
11

Distribution by Funding Stage

Other25 companies

Top Cities for Life Science

1.San Diego
2 companies$53.6M
2.Toronto
2 companies$1.3M
3.Oslo
2 companies$10.0M
4.San Francisco
2 companies$270.0M
5.Milano
1 companies$141.0M

Related Industries

Companies in the life science sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Life Science Startups?

Perfect for: B2B sales teams targeting life science companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked